» Articles » PMID: 36295624

Management of Lung Cancer Presenting with Solitary Bone Metastasis

Overview
Publisher MDPI
Specialty General Medicine
Date 2022 Oct 27
PMID 36295624
Authors
Affiliations
Soon will be listed here.
Abstract

Lung neoplasm is the main cause of cancer-related mortality, and bone metastasis is among the most common secondary tumors. The vast majority of patients also present with multiple bone metastases, which makes systemic and adjuvant pain therapy preferable to surgery. The optimal approach for a resectable non-small-cell lung tumor that also presents a unique, resectable bone metastasis is not fully established. The number of papers addressing this subject is small, and most are case reports; nevertheless, survival rates seem to increase with radical surgery. The sequencing of local versus systemic treatment should always be discussed within the multidisciplinary team that will choose the best approach for each patient. As targeted systemic therapies become more accessible, radical surgery, together with existing reconstructive methods, will lead to an increase in life expectancy and a better quality of life.

Citing Articles

The Constellation of Risk Factors and Paraneoplastic Syndromes in Cholangiocarcinoma: Integrating the Endocrine Panel Amid Tumour-Related Biology (A Narrative Review).

Ciobica M, Sandulescu B, Chicea L, Iordache M, Groseanu M, Carsote M Biology (Basel). 2024; 13(9).

PMID: 39336089 PMC: 11429066. DOI: 10.3390/biology13090662.


Bioinformatic analysis of differentially expressed genes in lung cancer bone metastasis and their implications for disease progression in lung cancer patients.

Hong Q, Hu H, Liu D, Hu X, Wang Z, Zhou D J Thorac Dis. 2024; 16(7):4666-4677.

PMID: 39144363 PMC: 11320291. DOI: 10.21037/jtd-24-1081.


Single-molecule targeted therapy shrinks lung lesions and improves bone metastases: A case report.

Wei J, Hu B, Fang H, Zhang F, Wang P Medicine (Baltimore). 2024; 103(29):e38874.

PMID: 39029067 PMC: 11398788. DOI: 10.1097/MD.0000000000038874.


Personalized Management of Malignant and Non-Malignant Ectopic Mediastinal Thyroid: A Proposed 10-Item Algorithm Approach.

Carsote M, Ciobica M, Sima O, Ciuche A, Popa-Velea O, Stanciu M Cancers (Basel). 2024; 16(10).

PMID: 38791947 PMC: 11120123. DOI: 10.3390/cancers16101868.


Primary Cardiac Intimal Sarcoma: Multi-Layered Strategy and Core Role of Amplification/Co-Amplification and Immunostaining.

Nistor C, Carsote M, Cucu A, Stanciu M, Popa F, Ciuche A Diagnostics (Basel). 2024; 14(9).

PMID: 38732333 PMC: 11083306. DOI: 10.3390/diagnostics14090919.


References
1.
Ettinger D, Wood D, Akerley W, Bazhenova L, Borghaei H, Camidge D . Non-Small Cell Lung Cancer, Version 6.2015. J Natl Compr Canc Netw. 2015; 13(5):515-24. DOI: 10.6004/jnccn.2015.0071. View

2.
Diel I, Mundy G . Bisphosphonates in the adjuvant treatment of cancer: experimental evidence and first clinical results. International Bone and Cancer Study Group (IBCG). Br J Cancer. 2000; 82(8):1381-6. PMC: 2363374. DOI: 10.1054/bjoc.1999.1077. View

3.
Knapp B, Devarakonda S, Govindan R . Bone metastases in non-small cell lung cancer: a narrative review. J Thorac Dis. 2022; 14(5):1696-1712. PMC: 9186248. DOI: 10.21037/jtd-21-1502. View

4.
Capanna R, Campanacci D . The treatment of metastases in the appendicular skeleton. J Bone Joint Surg Br. 2001; 83(4):471-81. DOI: 10.1302/0301-620x.83b4.12202. View

5.
Reyes L, Parvez Z, Nemoto T, Regal A, Takita H . Adrenalectomy for adrenal metastasis from lung carcinoma. J Surg Oncol. 1990; 44(1):32-4. DOI: 10.1002/jso.2930440108. View